EXTRA STRENGTH MAALOX PLUS "STRONGEST ANTACID" AD CLAIM
This article was originally published in The Tan Sheet
Executive Summary
EXTRA STRENGTH MAALOX PLUS "STRONGEST ANTACID" AD CLAIM may continue to be used by Rhone-Poulenc Rorer following a 2-to-1 decision by the U.S. Court of Appeals for the Third Circuit in Philadelphia on March 15. The appeals court upheld a lower court ruling that Johnson & Johnson/Merck failed to prove that RPR's "strongest antacid there is" claim for Extra Strength Maalox Plus in television ads is false and misleading to consumers and in violation of section 43(a) of the Lanham Act.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning